Targeted delivery of insoluble cargo (paclitaxel) by PEGylated chitosan nanoparticles grafted with Arg-Gly-Asp (RGD)

Molecular Pharmaceutics

Volumn 9, Issue 6, 2012, Pages 1736-1747

  Lv, Pi Ping ^a,c   Ma, Yu Feng ^b   Yu, Rong ^b   Yue, Hua ^a   Ni, De Zhi ^a,c   Wei, Wei ^a   Ma, Guang Hui ^a  

^a INSTITUTE OF PROCESS ENGINEERING   (China)

^b SICHUAN UNIVERSITY   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

crystallization; drug delivery; nanoparticles; RGD peptide

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; CHITOSAN DERIVATIVE; NANOCRYSTAL; NANOPARTICLE; PACLITAXEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER INHIBITION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EMULSION; EXTRACELLULAR MATRIX; IN VITRO STUDY; IN VIVO STUDY; LEWIS CARCINOMA; MALE; MOUSE; NERVE CELL NETWORK; NONHUMAN; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM;

ANIMALS; CELL LINE, TUMOR; CHITOSAN; DRUG CARRIERS; EMULSIONS; INJECTIONS, INTRAVENOUS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; NANOPARTICLES; NIH 3T3 CELLS; OLIGOPEPTIDES; PACLITAXEL;

EID: 84862015364     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp300051h     Document Type: Article

References (29)

1. Jemal, A. Cancer Statistics. Ca - Cancer J. Clin. 2011, 61, 212-236.
2. Yue, Z. G.; Wei, W.; You, Z. X.; Yang, Q. Z.; Yue, H.; Su, Z. G; Ma, G. H. Iron oxide nanotubes for magnetically guided delivery and pH-activated release of insoluble anticancer drugs. Adv. Funct. Mater. 2011, 21, 3446-3453.
3. Lukyanov, A. N.; Torchilin, V. P. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. Adv. Drug Delivery Rev. 2004, 56, 1273-1289. (Pubitemid 38510474)
4. Danhier, F.; Lecouturier, N.; Vroman, B.; Jerome, C.; Marchand-Brynaert, J.; Feron, O.; Préat, V. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation. J. Controlled Release 2009, 133, 11-17.
5. Allen, T. M.; Cullis, P. R. Drug delivery systems: entering the mainstream. Science 2004, 303, 1818-1822. (Pubitemid 38374867)
6. Yao, H. J.; Ju, R. J.; Wang, X. X.; Zhang, Y.; Li, R. J.; Yu, Y.; Zhang, L.; Lu, W. L. The antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral delivery. Biomaterials 2011, 32, 3285-3302.
7. Acharya, S.; Sahoo, S. K. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv. Drug Delivery Rev. 2011, 63, 170-183.
8. Ashley, C. E.; Carnes, E. C.; Phillips, G. K.; Padilla, D.; Durfee, P. N.; Brown, P. A.; Hanna, T. N.; Liu, J.; Phillips, B.; Carter, M. B.; Carroll, N. J.; Jiang, X. M.; Dunphy, D. R.; Willman, C. L.; Petsev, D. N.; Evans, D. G.; Parikh, A. N.; Chackerian, B.; Wharton, W.; Peabody, D. S.; Brinker, C. J. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nat. Mater. 2011, 10, 389-397.
9. Miki, K.; Kimura, A.; Oride, K.; Kuramochi, Y.; Matsuoka, H.; Harada, H.; Hiraoka, M.; Ohe, K. High-contrast fluorescence imaging of tumors in vivo using nanoparticles of amphiphilic brush-Like copolymers produced by ROMP. Angew. Chem., Int. Ed. 2011, 50, 6567-6570.
10. Chan, J. M.; Zhang, L. F.; Yuet, K. P.; Liao, G.; Rhee, J. W.; Langer, R.; Farokhzad, O. C. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials 2009, 30, 1627-1634.
11. Yong, K. T.; Hu, R.; Roy, I.; Ding, H.; Vathy, L. A.; Bergey, E. J.; Mizuma, M.; Maitra, A.; Prasad, P. N. Tumor targeting and imaging in live animals with functionalized semiconductor quantum Rods. ACS Appl. Mater. Interfaces 2009, 1, 710-719.
12. de Abreu, F. R.; Campana, S. P. Characteristics and properties of carboxymethylchitosan. Carbohydr. Polym. 2009, 75, 214-221.
13. Chen, X. G.; Park, H. J. Chemical characteristics of Ocarboxymethyl chitosans related to the preparation conditions. Carbohydr. Polym. 2003, 53, 355-359.
14. Lv, P. P.; Wei, W.; Gong, F. L.; Zhang, Y. L.; Zhao, H. Y.; Lei, J. D.; Wang, L. Y.; Ma, G. H. Preparation of uniformly sized chitosan nanospheres by a premix membrane emulsification technique. Ind. Eng. Chem. Res. 2009, 48, 8819-8828.
15. Lv, P. P.; Wei, W.; Yue, H.; Yang, T. Y.; Wang, L. Y.; Ma, G. H. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration. Biomacromolecules 2011, 12, 4230-4239.
16. Lim, S. M.; Kim, T. H.; Jiang, H. H.; Park, C. W.; Lee, S.; Chen, X.; Lee, K. C. Improved biological half-life and anti-tumor activity of TNF-related apoptosis-inducing ligand (TRAIL) using PEG-exposed nanoparticles. Biomaterials 2011, 32, 3538-3546.
17. Zhan, C. Y.; Gu, B.; Xie, C.; Li, J.; Liu, Y.; Lu, W. Y. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. J. Controlled Release 2010, 143, 136-142.
18. Wei, Q.; Wei, W.; Tian, R.; Wang, L. Y.; Su, Z. G.; Ma, G. H. Preparation of uniform-sized PELA microspheres with high encapsulation efficiency of antigen by premix membrane emulsification. J. Colloid Interface Sci. 2008, 323, 267-273.
19. Wei, W.; Wang, L. Y.; Yuan, L.; Wei, Q.; Yang, X. D.; Su, Z. G.; Ma, G. H. Preparation and application of novel microspheres possessing autofluorescent properties. Adv. Funct. Mater. 2007, 17, 3153-3158.
20. Danhier, F.; Vroman, B.; Lecouturier, N.; Crokart, N.; Pourcelle, V.; Freichels, H.; Jérôme, C.; Marchand-Brynaert, J.; Ferond, O.; Preat, V. Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel. J. Controlled Release 2009, 140, 166-173.
21. Wang, L. Y.; Ma, G. H.; Su, Z. G. Preparation of uniform sized chitosan microspheres by membrane emulsification technique and application as a carrier of protein drug. J. Controlled Release 2005, 106, 62-75.
22. Maeda, H.; Bharate, G. Y.; Daruwalla, J. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur. J. Pharm. Biopharm. 2009, 7, 409-419.
23. Sugahara, K. N.; Teesalu, T.; Karmali, P. P.; Kotamraju, V. R.; Agemy, L.; Greenwald, D. R.; Ruoslahti, E. Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. Science 2010, 328, 1031-1035.
24. Wietrzyk, J.; Filip, B.; Milczarek, M.; Klopotowska, D.; Maciejewska, M.; Dabrowska, K.; Kurzepa, A.; Dzimira, S.; Madej, J.; Kutner, A. The influence of 1,25-dihydroxyvitamin D3 and 1,24-dihydroxyvitamin D3 on alphavbeta3 integrin expression in cancer cell lines. Oncol. Rep. 2008, 20, 941-952.
25. Feng, S. S.; Mei, L.; Anitha, P.; Gan, C. W.; Zhou, W. Y. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of docetaxel. Biomaterials 2009, 30, 3297-3306.
26. Wang, C.; Lv, P. P.; Wei, W.; Tao, S. Y.; Hu, T.; Yang, J. B.; Meng, C. G. A smart multifunctional nanocomposite for intracellular targeted drug delivery and self-release. Nanotechnology 2011, 22, 1-8.
27. Ray, M. A.; Trammell, R. A.; Verhulst, S.; Ran, S.; Toth, L. A. Development of a mouse model for assessing fatigue during chemotherapy. Comp. Med. 2011, 61, 119-30.
28. Yakabe, T.; Noshiro, H.; Ikeda, O.; Miyoshi, A.; Kitajima, Y.; Satoh, S. Second-line chemotherapy with paclitaxel and doxifluridine after failure of S-1 in elderly patients with unresectable advanced or recurrent gastric cancer. J. Cancer Res. Clin. 2011, 137, 1499-1504.
29. Boy, J.; Schmidt, T.; Schumann, U.; Grasshoff, U.; Unser, S.; Holzmann, C.; Schmitt, I.; Karl, T.; Laccone, F.; Wolburg, H.; Ibrahim, S.; Riess, O. A transgenic mouse model of spinocerebellar ataxia type 3 resembling late disease onset and gender-specific instability of CAG repeats. Neurobiol. Dis. 2010, 37, 284-293.